← Human Trials & Peer-Reviewed Studies

Vitamin D supplementation during pregnancy and infancy reduces aeroallergen sensitization: a randomized controlled trial.

Plain-language guide to PMID 27060679 (2016): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc.

Key Facts

PMID
27060679
Journal
Allergy
Year
2016
Study type
Randomized Controlled Trial
Authors
Grant CC et al. (9 authors)
DOI
10.1111/all.12909

What This Study Did, in Plain Language

What Was Tested

Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.

Vitamin D has immune-modulating effects.

Who Took Part

By PubMed's age tags, the people studied were infants, both men and women.

When the children were 18 months old, the researchers measured serum-specific IgE antibodies and identified acute primary care visits described by the doctor to be due to a cold, otitis media, an upper respiratory infection, croup, asthma, bronchitis, bronchiolitis, a wheezy lower respiratory infection or fever and cough.

How the Study Was Run

The researchers set it up as a randomized, double-blind, placebo-controlled and parallel-group study.

The participants were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.

As a double-blind Vitamin D, K2, Magnesium and Zinc study, the assignments were hidden from both participants and investigators until the end.

A placebo (an inactive look-alike) gave the Vitamin D, K2, Magnesium and Zinc group a baseline to be compared against.

Groups ran in parallel: each of the participants stayed in one arm throughout.

A randomized, double-blind, placebo-controlled parallel-group trial.

What Was Measured

The subject headings attached to it are Allergens, Comorbidity, Dietary Supplements, Hypersensitivity, Hypersensitivity, Immediate, Immunoglobulin E and Maternal Exposure.

Author keywords: Vitamin D, 25-hydroxyvitamin D, asthma, infant, pregnancy and supplementation.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc.

Its findings take up roughly 6 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2016 (Allergy), a journal based in Denmark.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.